{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T21:28:49Z","timestamp":1774733329032,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ijbiomac.2025.146659","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T15:03:11Z","timestamp":1754492591000},"page":"146659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P4","title":["Mapping novel linear B-cell epitopes target Hepatitis C virus envelope proteins E1 and E2 by monoclonal antibodies for increasing the sensitive detection sites"],"prefix":"10.1016","volume":"321","author":[{"given":"Yuanyuan","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sen","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanglin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junxian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xifang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7053","key":"10.1016\/j.ijbiomac.2025.146659_bb0005","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nature04079","article-title":"Adaptive immune responses in acute and chronic hepatitis C virus infection","volume":"436","author":"Bowen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.146659_bb0010","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1073\/pnas.88.6.2451","article-title":"Genetic organization and diversity of the hepatitis C virus","volume":"88","author":"Choo","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7053","key":"10.1016\/j.ijbiomac.2025.146659_bb0015","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nature04077","article-title":"Unravelling hepatitis C virus replication from genome to function","volume":"436","author":"Lindenbach","year":"2005","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.146659_bb0020","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1128\/JVI.02642-06","article-title":"Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus","volume":"81","author":"Lavillette","year":"2007","journal-title":"J. Virol."},{"issue":"42","key":"10.1016\/j.ijbiomac.2025.146659_bb0025","doi-asserted-by":"crossref","first-page":"41003","DOI":"10.1074\/jbc.M302267200","article-title":"Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate","volume":"278","author":"Barth","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"43","key":"10.1016\/j.ijbiomac.2025.146659_bb0030","doi-asserted-by":"crossref","first-page":"41624","DOI":"10.1074\/jbc.M305289200","article-title":"Cell entry of hepatitis C virus requiresa set of co-receptors that include the CD81 tetraspanin and the SR-B1scavenger receptor","volume":"278","author":"Bartosch","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.146659_bb0035","doi-asserted-by":"crossref","first-page":"10677","DOI":"10.1128\/JVI.77.19.10677-10683.2003","article-title":"CD81-dependent binding of hepatitis C virus E1E2 heterodimers","volume":"77","author":"Cocquerel","year":"2003","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146659_bb0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge","volume":"14","author":"Law","year":"2008","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146659_bb0045","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/hep.22244","article-title":"Polyclonal immunoglobulins from achronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain","volume":"47","author":"Vanwolleghem","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2025.146659_bb0050","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1128\/jvi.69.7.4407-4412.1995","article-title":"Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients","volume":"69","author":"Scarselli","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2025.146659_bb0055","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1073\/pnas.89.8.3468","article-title":"Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections","volume":"89","author":"Weiner","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.146659_bb0060","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1006\/viro.1995.1196","article-title":"Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment","volume":"208","author":"Zibert","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.ijbiomac.2025.146659_bb0065","doi-asserted-by":"crossref","first-page":"15394","DOI":"10.1073\/pnas.93.26.15394","article-title":"Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein","volume":"93","author":"Farci","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.146659_bb0070","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1128\/jvi.67.7.3923-3930.1993","article-title":"Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus","volume":"67","author":"Kato","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2025.146659_bb0075","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1006\/viro.1994.1582","article-title":"Influence of antibodies to the hypervariable region of E2\/NS1 glycoprotein on the selective replication of hepatitis C virus in chimpanzees","volume":"204","author":"Kojima","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.ijbiomac.2025.146659_bb0080","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1128\/jvi.68.3.1494-1500.1994","article-title":"Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses","volume":"68","author":"Shimizu","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2025.146659_bb0085","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1006\/viro.1994.1182","article-title":"Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus glycoprotein using a yeast peptide library","volume":"200","author":"Mink","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.ijbiomac.2025.146659_bb0090","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1128\/jvi.71.9.7101-7109.1997","article-title":"Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode","volume":"71","author":"Nakano","year":"1997","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146659_bb0095","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1080\/22221751.2022.2109515","article-title":"Identification of three conserved linear B cell epitopes on the SARS-CoV-2 spike protein","volume":"11","author":"Wang","year":"2022","journal-title":"Emerg. Microbes Infect."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.146659_bb0100","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1128\/JVI.78.13.7257-7263.2004","article-title":"Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivity","volume":"78","author":"Keck","year":"2004","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146659_bb0105","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2893.2002.00358.x","article-title":"Mapping and characterization of B cell linear epitopes in the conservative regions of hepatitis C virus envelope glycoproteins","volume":"9","author":"Olenina","year":"2002","journal-title":"J. Viral Hepat."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146659_bb0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/JVI.73.1.11-18.1999","article-title":"Identification of a domain containing B-cell epitopes in hepatitis C virus E2 glycoprotein by using mouse monoclonal antibodies","volume":"73","author":"Lee","year":"1999","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146659_bb0115","article-title":"A neutralization epitope in the hepatitis C virus E2 glycoprotein interacts with host entry factor CD81","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146659_bb0120","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1099\/jgv.0.000735","article-title":"Identification of a novel epitope in the C terminus of hepatitis C virus-E2 protein that induces potent and cross-reactive neutralizing antibodies","volume":"98","author":"Das","year":"2017","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ijbiomac.2025.146659_bb0125","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1073\/pnas.1114927109","article-title":"Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus","volume":"109","author":"Giang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146659_bb0130","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jceh.2017.12.010","article-title":"Structural and epitope analysis (T- and B-cell epitopes) of Hepatitis C Virus (HCV) glycoproteins: an in silico approach","volume":"8","author":"Kumar","year":"2018","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146659_bb0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12026-017-8962-7","article-title":"Screening HCV genotype-specific epitope peptides based on conserved sequence analysis and B cell epitope prediction in HCV E2 region","volume":"66","author":"Hua","year":"2018","journal-title":"Immunol. Res."},{"issue":"Suppl. 4","key":"10.1016\/j.ijbiomac.2025.146659_bb0140","first-page":"S3","article-title":"Prediction of linear B-cell epitopes of hepatitis C virus for vaccine development","volume":"8","author":"Huang","year":"2015","journal-title":"BMC Med. Genet."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146659_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22410","article-title":"Evaluation of a recombinant multiepitope antigen for diagnosis of hepatitis C virus: a lower cost alternative for antigen production","volume":"32","author":"Thomasini","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146659_bb0150","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1128\/JCM.43.8.3917-3924.2005","article-title":"Design of novel conformational and genotype-specific antigens for improving sensitivity of immunoassays for hepatitis C virus-specific antibodies","volume":"43","author":"Lin","year":"2005","journal-title":"J. Clin. Microbiol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025072162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025072162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T06:03:12Z","timestamp":1755237792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025072162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":30,"alternative-id":["S0141813025072162"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146659","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping novel linear B-cell epitopes target Hepatitis C virus envelope proteins E1 and E2 by monoclonal antibodies for increasing the sensitive detection sites","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146659","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"146659"}}